Implant placement in edentulous site.
Conditions
Interventions
Intervention 1: Intervention group:Placement of LPRF membrane obtained from 20 cc of patient venous blood on the implant before placement in bone during surgery. Intervention 2: Control group: Implant
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adults (over 18 years old) healthy persons overall plaque index under 25% sufficient bone volume in vertical and horizontal lines sufficient mesiodistal and interocclusal space
Exclusion criteria
Exclusion criteria: Diabetic patients or any other disease that affects bone metabolism pregnant patients people who use corticosteroids or other immune system suppressors people who got bone graft or sinus floor augmentation previously
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ISQ score. Timepoint: On the day of surgery immediately after implant placement and in the week 2-4-6-8-12 after surgery. Method of measurement: Osstell device.;The amount of marginal bone loss around implant. Timepoint: On the day of surgery immediately after implant placement and 12 weeks later. Method of measurement: Parallel periapical radiography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMeshkat naeimi darestani
Tehran University of Medical Sciences
Outcome results
None listed